#BEGIN_DRUGCARD DB02475

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
15426

# Chemical_Formula:
C9H16N4O3

# Chemical_IUPAC_Name:
(2R)-5-carbamimidamido-2-(2-oxoazetidin-1-yl)pentanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Deoxyguanidinoproclavaminic acid

# HET_ID:
PCX

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C9H16N4O3/c10-9(11)12-4-1-2-6(8(15)16)13-5-3-7(13)14/h6H,1-5H2,(H,15,16)(H4,10,11,12)/t6-/m1/s1

# InChI_Key:
InChIKey=UYADDEKIZFRINK-ZCFIWIBFSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C06656

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2475

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
228.2483

# Molecular_Weight_Mono:
228.122240398

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1GVG

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.4

# Predicted_LogS:
-2.2

# Predicted_Water_Solubility:
1.38e+00 g/l

# Primary_Accession_No:
DB02475

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936400

# PubChem_Substance_ID:
46508834

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02527

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC(=N)NCCC[C@@H](N1CCC1=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Deoxyamidinoproclavaminate

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:10 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AF071051

# Drug_Target_1_GenBank_ID_Protein:
3420295

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
bls

# Drug_Target_1_Gene_Sequence:
>1542 bp
ATGGGGGCACCGGTTCTTCCGGCTGCCTTCGGGTTCCTGGCCTCCGCCCGAACGGGCGGG
GGCCGGGCCCCCGGCCCGGTCTTCGCGACCCGGGGCAGCCACACCGACATCGACACGCCC
CAGGGGGAGCGCTCGCTCGCGGCGACCCTGGTGCACGCCCCCTCGGTCGCGCCCGACCGC
GCGGTGGCGCGCTCCCTCACCGGCGCGCCCACCACCGCGGTGCTCGCCGGTGAGATCTAC
AACCGGGACGAACTCCTCTCCGTGCTGCCCGCCGGACCCGCGCCGGAGGGGGACGCGGAG
CTGGTCCTGCGGCTGCTGGAACGCTATGACCTGCATGCCTTCCGGCTGGTGAACGGGCGC
TTCGCGACCGTGGTGCGGACCGGGGACCGGGTCCTGCTCGCCACCGACCACGCCGGTTCG
GTGCCGCTGTACACCTGTGTGGCGCCGGGCGAGGTCCGGGCGTCCACCGAGGCCAAGGCG
CTCGCCGCGCACCGCGACCCGAAGGGCTTCCCGCTCGCGGACGCCCGCCGGGTCGCCGGT
CTGACCGGTGTCTACCAGGTGCCCGCGGGCGCCGTGATGGACATCGACCTCGGCTCGGGC
ACCGCCGTCACCCACCGCACCTGGACCCCGGGCCTCTCCCGCCGCATCCTGCCGGAGGGC
GAGGCCGTCGCGGCCGTGCGGGCCGCGCTGGAGAAGGCCGTCGCCCAGCGGGTCACCCCC
GGCGACACCCCGTTGGTGGTGCTCTCCGGCGGAATCGACTCCTCCGGGGTCGCGGCCTGT
GCGCACCGGGCGGCCGGGGAACTGGACACGGTGTCCATGGGCACCGACACGTCCAACGAG
TTCCGCGAGGCCCGGGCGGTCGTCGACCATCTGCGCACCCGGCACCGGGAGATCACCATC
CCGACCACCGAGCTGCTGGCGCAGCTCCCGTACGCGGTGTGGGCCTCCGAGTCGGTGGAC
CCGGACATCATCGAGTACCTGCTCCCCCTGACAGCGCTCTACCGGGCGCTCGACGGGCCG
GAGCGCCGCATCCTCACCGGGTACGGCGCGGACATCCCCCTCGGGGGCATGCACCGCGAG
GACCGGCTGCCCGCGCTGGACACCGTTCTCGCGCACGACATGGCCACCTTCGACGGGCTG
AACGAGATGTCCCCGGTGCTGTCCACGCTGGCGGGGCACTGGACCACCCACCCGTACTGG
GACCGGGAGGTCCTCGATCTGCTGGTCTCGCTGGAGGCCGGGCTCAAGCGGCGGCACGGC
CGGGACAAGTGGGTGCTGCGCGCCGCGATGGCCGACGCCCTCCCGGCGGAGACCGTCAAC
CGGCCCAAGCTGGGCGTCCACGAGGGCTCGGGCACCACGTCCTCGTTCTCCCGGCTGCTG
CTGGACCACGGTGTCGCCGAGGACCGCGTCCACGAGGCGAAGCGGCAGGTGGTGCGCGAG
CTGTTCGATCTCACGGTCGGGGGCGGACGGCACCCCTCCGAGGTGGACACCGACGATGTG
GTGCGCTCCGTGGCCGACCGGACCGCGCGGGGGGCGGCCTAG

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
10681345	Jensen SE, Elder KJ, Aidoo KA, Paradkar AS: Enzymes catalyzing the early steps of clavulanic acid biosynthesis are encoded by two sets of paralogous genes in Streptomyces clavuligerus. Antimicrob Agents Chemother. 2000 Mar;44(3):720-6.
9689037	Bachmann BO, Li R, Townsend CA: beta-Lactam synthetase: a new biosynthetic enzyme. Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9082-6.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2885

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
54530

# Drug_Target_1_Name:
Carboxyethyl-arginine beta-lactam-synthase

# Drug_Target_1_Number_of_Residues:
513

# Drug_Target_1_PDB_ID:
1MC1

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00733	Asn_synthase

# Drug_Target_1_Protein_Sequence:
>Carboxyethyl-arginine beta-lactam-synthase
MGAPVLPAAFGFLASARTGGGRAPGPVFATRGSHTDIDTPQGERSLAATLVHAPSVAPDR
AVARSLTGAPTTAVLAGEIYNRDELLSVLPAGPAPEGDAELVLRLLERYDLHAFRLVNGR
FATVVRTGDRVLLATDHAGSVPLYTCVAPGEVRASTEAKALAAHRDPKGFPLADARRVAG
LTGVYQVPAGAVMDIDLGSGTAVTHRTWTPGLSRRILPEGEAVAAVRAALEKAVAQRVTP
GDTPLVVLSGGIDSSGVAACAHRAAGELDTVSMGTDTSNEFREARAVVDHLRTRHREITI
PTTELLAQLPYAVWASESVDPDIIEYLLPLTALYRALDGPERRILTGYGADIPLGGMHRE
DRLPALDTVLAHDMATFDGLNEMSPVLSTLAGHWTTHPYWDREVLDLLVSLEAGLKRRHG
RDKWVLRAAMADALPAETVNRPKLGVHEGSGTTSSFSRLLLDHGVAEDRVHEAKRQVVRE
LFDLTVGGGRHPSEVDTDDVVRSVADRTARGAA

# Drug_Target_1_Reaction:
ATP + L-N2-(2-carboxyethyl)arginine = AMP + diphosphate + deoxyamidinoproclavaminate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
ATP + L-2-N-(2-carboxyethyl)arginine = AMP + diphosphate + deoxyamidinoproclavaminate

# Drug_Target_1_SwissProt_ID:
Q9R8E3

# Drug_Target_1_SwissProt_Name:
BLS_STRCL

# Drug_Target_1_Synonyms:
Beta-lactam synthetase
EC 6.3.3.4

# Drug_Target_1_Theoretical_pI:
6.33

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
L06213

# Drug_Target_2_GenBank_ID_Protein:
153220

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
cs1

# Drug_Target_2_Gene_Sequence:
>975 bp
ATGACCTCAGTGGACTGCACCGCGTACGGCCCCGAGCTGCGCGCGCTCGCCGCCCGGCTG
CCCCGGACCCCCCGGGCCGACCTGTACGCCTTCCTGGACGCCGCGCACACAGCCGCCGCC
TCGCTCCCCGGCGCCCTCGCCACCGCGCTGGACACCTTCAACGCCGAGGGCAGCGAGGAC
GGCCATCTGCTGCTGCGCGGCCTCCCGGTGGAGGCCGACGCCGACCTCCCCACCACCCCG
AGCAGCACCCCGGCGCCCGAGGACCGCTCCCTGCTGACCATGGAGGCCATGCTCGGACTG
GTGGGCCGCCGGCTCGGTCTGCACACGGGGTACCGGGAGCTGCGCTCGGGCACGGTCTAC
CACGACGTGTACCCGTCGCCCGGCGCGCACCACCTGTCCTCGGAGACCTCCGAGACGCTG
CTGGAGTTCCACACGGAGATGGCCTACCACCGGCTCCAGCCGAACTACGTCATGCTGGCC
TGCTCCCGGGCCGACCACGAGCGCACGGCGGCCACACTCGTCGCCTCGGTCCGCAAGGCG
CTGCCCCTGCTGGACGAGAGGACCCGGGCCCGGCTCCTCGACCGGAGGATGCCCTGCTGC
GTGGATGTGGCCTTCCGCGGCGGGGTGGACGACCCGGGCGCCATCGCCCAGGTCAAACCG
CTCTACGGGGACGCGGACGATCCCTTCCTCGGGTACGACCGCGAGCTGCTGGCGCCGGAG
GACCCCGCGGACAAGGAGGCCGTCGCCGCCCTGTCCAAGGCGCTCGACGAGGTCACGGAG
GCGGTGTATCTGGAGCCCGGCGATCTGCTGATCGTCGACAACTTCCGCACCACGCACGCG
CGGACGCCGTTCTCGCCCCGCTGGGACGGGAAGGACCGCTGGCTGCACCGCGTCTACATC
CGCACCGACCGCAATGGACAGCTCTCCGGCGGCGAGCGCGCGGGCGACGTCGTCGCCTTC
ACACCGCGCGGCTGA

# Drug_Target_2_General_Function:
Involved in oxidoreductase activity

# Drug_Target_2_General_References:
1472501	Marsh EN, Chang MD, Townsend CA: Two isozymes of clavaminate synthase central to clavulanic acid formation: cloning and sequencing of both genes from Streptomyces clavuligerus. Biochemistry. 1992 Dec 22;31(50):12648-57.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2400

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
35370

# Drug_Target_2_Name:
Clavaminate synthase 1

# Drug_Target_2_Number_of_Residues:
324

# Drug_Target_2_PDB_ID:
1GVG

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF02668	TauD

# Drug_Target_2_Protein_Sequence:
>Clavaminate synthase 1
MTSVDCTAYGPELRALAARLPRTPRADLYAFLDAAHTAAASLPGALATALDTFNAEGSED
GHLLLRGLPVEADADLPTTPSSTPAPEDRSLLTMEAMLGLVGRRLGLHTGYRELRSGTVY
HDVYPSPGAHHLSSETSETLLEFHTEMAYHRLQPNYVMLACSRADHERTAATLVASVRKA
LPLLDERTRARLLDRRMPCCVDVAFRGGVDDPGAIAQVKPLYGDADDPFLGYDRELLAPE
DPADKEAVAALSKALDEVTEAVYLEPGDLLIVDNFRTTHARTPFSPRWDGKDRWLHRVYI
RTDRNGQLSGGERAGDVVAFTPRG

# Drug_Target_2_Reaction:
(1) deoxyamidinoproclavaminate + 2-oxoglutarate + O2 = amidinoproclavaminate + succinate + CO2

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Deoxyamidinoproclavaminate + 2-oxoglutarate + O(2) = amidinoproclavaminate + succinate + CO(2) + H(2)O

# Drug_Target_2_SwissProt_ID:
Q05581

# Drug_Target_2_SwissProt_Name:
CAS1_STRCL

# Drug_Target_2_Synonyms:
CAS1
CS1
Clavaminic acid synthetase 1
EC 1.14.11.21

# Drug_Target_2_Theoretical_pI:
5.24

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB02475
